Aby wyświetlić tę treść, wymagana jest subskrypcja JoVE. Zaloguj się lub rozpocznij bezpłatny okres próbny.
Method Article
A simple and reliable method on isolation and culture of neural stem cells from discarded human fetal cortical tissue is described. Cultures derived from known human neurological disorders can be used for characterization of pathological cellular and molecular processes, as well as provide a platform to assess pharmacological efficacy.
Neural stem cells (NSCs) reside along the ventricular zone neuroepithelium during the development of the cortical plate. These early progenitors ultimately give rise to intermediate progenitors and later, the various neuronal and glial cell subtypes that form the cerebral cortex. The capacity to generate and expand human NSCs (so called neurospheres) from discarded normal fetal tissue provides a means with which to directly study the functional aspects of normal human NSC development 1-5. This approach can also be directed toward the generation of NSCs from known neurological disorders, thereby affording the opportunity to identify disease processes that alter progenitor proliferation, migration and differentiation 6-9. We have focused on identifying pathological mechanisms in human Down syndrome NSCs that might contribute to the accelerated Alzheimer's disease phenotype 10,11. Neither in vivo nor in vitro mouse models can replicate the identical repertoire of genes located on human chromosome 21.
Here we use a simple and reliable method to isolate Down syndrome NSCs from aborted human fetal cortices and grow them in culture. The methodology provides specific aspects of harvesting the tissue, dissection with limited anatomical landmarks, cell sorting, plating and passaging of human NSCs. We also provide some basic protocols for inducing differentiation of human NSCs into more selective cell subtypes.
1. Preparation of solutions and materials for dissection and maintenance of neural stem cell culture
2. Isolating human neural stem cells from the human fetal brain
3. Manipulaton of neural stem cells for further characterization or experimentations
4. Freezing neural stem cells and subcultures
5. Representative Results:
Neural stem cells from a normal fetus at 18 weeks gestational age were cultured following the described methods and neurospheres can be seen after one week with round, smooth borders and fairly homogenous size (Fig.2A). These neurospheres can be transfected with EGFP-C1 or other constructs and followed under fluorescence microscopy (Fig.2B,). Established neurospheres were then dissociated with EDTA and plated as dispersed cells on coated coverslips. Cells differentiated under the respective protocols were fixed with 4% parafamaldehyde, and stained with different cell type specific markers. Multipotentiality is observed with expression of markers indicative of neurons (Fig2C, D, rhodamine) astrocytes (Fig2E, F, rhodamine) and oligodendrocytes (Fig2G, H, rhodamine). The cells not undergone electroporation of EGFP were also differentiated into different cell types and stained with different cell specific markers. Multipotentiality is observed with expression of markers indicative of neurons (Fig3A, B, fluoroscein) astrocytes (Fig3C, rhodamine and Fig3D, fluoroscein) and oligodendrocytes (Fig3E, F, rhodamine).
Figure 1. Schematic of the experimental procedure to isolate neural stem cells from discarded human fetal brain
Figure 2. Undifferentiated and differentiated human neural cells propogated in vitro. (A) Neurospheres are shown under phase contrast microscopy demonstrate smooth, round borders and rapid growth after culture for over 1 week. (B) Introduction of various plasmids and constructs can be achieved through transfection. Three days following EGFP-C1 transfection, multiple cells show expression of the green fluorescent protein as seen under fluoroscein immunostaining and fluorescence microscopy. EGFP-C1 transfected neurospheres are dissociated and differentiated under different conditions into neurons (C, D), astrocytes (E, F) and oligodendrocytes (G, H) and seen under rhodamine fluorescence. Concurrently, transfected EGFP positive cells are shown under fluoroscein fluorescence. Transfected cells (white arrow heads) are indistinguishable from untransfected cells (white arrows). The cell nuclei are stained with Hoechst33342. Scale bars are 200 μm for A, 100 μm for B and 25 μm for C-H.
Figure 3. Neurospheres without transfection are dissociated and differentiated under different conditions into neurons (A, B, fluoroscein), astrocytes (C, rhodamine, D, fluoroscein) and oligodendrocytes (E, F, rhodamine). The cell nuclei are stained with Hoechst33342. Scale bars are 25 μm for A-F.
Access restricted. Please log in or start a trial to view this content.
There are various approaches toward culture fresh tissue and producing human cell lines. Historically, fresh tissue has been harvested and cultured immediately to generate various cell types in the central nervous system. This approach however is clearly limited by the number of samples that can be obtained- which in the case for human samples, is usually quite small. Given the minimal degree of manipulation, freshly cultured neural cells provide the most reliable experimental system by limiting potential artifacts from ...
Access restricted. Please log in or start a trial to view this content.
No conflicts of interest declared.
This work was supported in part by the National Institutes of Health: HD054347 and NS063997-01 to VLS. This work was also supported in part by the Empire State Stem Cell Fund through the New York State Department of Health Contract #C024324 to VLS. The opinions expressed here are solely those of the author and do not necessarily reflect those of the Empire State Stem Cell Board, the New York State Department of Health, or the State of New York. VLS is a Doris Duke Clinical Scientist Developmental Award Recipient. We also thank Professor Timothy Vartanian for his gift of Anti-O1, Anti-O4 antibodies.
Access restricted. Please log in or start a trial to view this content.
Name | Company | Catalog Number | Comments |
KNOCKOUT DMEM/F12 | Invitrogen | 12660-012 | Dissociation medium |
Stem Pro NSC SFM | Invitrogen | A10509-01 | Culture medium |
Fetal Bovine Serum | Invitrogen | 10091-148 | Frozen medium |
Hanks solution (-Ca2+, -Mg2+) | Invitrogen | 14175-095 | Dissociation medium |
DMSO | Sigma-Aldrich | D2650 | Frozen medium |
EDTA | Sigma-Aldrich | 431788 | Dissociation medium |
Paraformaldehyde | Sigma-Aldrich | 158127 | Fixation solution |
bFGF | R&D Systems | 234-FSE | Differentiation medium |
SHH | R&D Systems | 1845-SH | Differentiation medium |
PDGF-AA | R&D Systems | 221-AA | Differentiation medium |
B27 | Invitrogen | 17504-044 | Differentiation medium |
Mouse Anti-MAP2 | Sigma-Aldrich | M2320 | 1:200 |
Rabbit Anti-DCX | Cell Signaling Technology | 4604s | 1:200 |
Rabbit Anti-GFAP | Dako | Z0334 | 1:200 |
Rabbit Anti-S100B | Dako | Z0311 | 1:200 |
Rabbit Anti-O1 | gifts of Professor Timothy Vartanian* | 1:50 | |
Rabbit Anti-O4 | Gifts of Professor Timothy Vartanian* | 1:50 | |
40μm cell strainer | BD Biosciences | 352340 | |
* Timothy Vartanian, MD, PhD, Department of Neurology and Neuroscience, Weill Cornell Medical College, New York, USA |
Access restricted. Please log in or start a trial to view this content.
Zapytaj o uprawnienia na użycie tekstu lub obrazów z tego artykułu JoVE
Zapytaj o uprawnieniaThis article has been published
Video Coming Soon
Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone